Ledger.Open graph →
SEC Form D · filed December 24, 2014

Audentes Therapeutics, Inc

Offering
$42.5M
Sold
$42.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Matthew Patterson · San Francisco, CAExec · DirectorThomas Schuetz · San Francisco, CADirectorJonathan Silverstein · San Francisco, CADirectorThomas Woiwode · Menlo Park, CADirectorR. C. Pica · San Bruno, CADirectorCraig Kaplan · Capitola, CAExec · DirectorKush Parmar · Boston, MADirectorJonathan Leff · South San Francisco, CADirectorDoug C. Pica · San Bruno, CADirectorSteven Waldman · Brooklyn, NYExec · DirectorKush Parmar · San Francisco, CADirectorJonathan Silverstein · New York, NYDirectorThomas Woiwode · Menlo Park, CADirectorJonathan Leff · San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗